EASY BIO,Inc. (KOSDAQ:353810)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,320.00
+30.00 (0.48%)
Sep 4, 2026, 3:30 PM KST

EASY BIO,Inc. Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
525,038476,939384,331165,385155,557129,458
Revenue Growth
15.45%24.10%132.38%6.32%20.16%-
Cost of Revenue
386,769356,446286,243113,682108,61289,388
Gross Profit
138,269120,49398,08851,70346,94540,070
Selling, General & Admin
74,50166,29156,93127,71026,95220,575
Research & Development
3,3653,1183,0342,4872,4261,744
Amortization of Goodwill & Intangibles
3,0562,7072,287438.05323.7112.06
Other Operating Expenses
2,6782,2832,140268.54217.04167.89
Operating Expenses
85,15375,50465,69731,07230,79023,291
Operating Income
53,11644,99032,39120,63116,15516,779
Interest Expense
-6,190-7,535-9,025-3,219-1,720-1,105
Interest & Investment Income
2,0372,4753,2991,333534.54347.87
Currency Exchange Gain (Loss)
7,368-1,1582,558981.1-1,670-160.27
Other Non Operating Income (Expenses)
-874.61-926.25-1,529-1,878-1,907-1,821
EBT Excluding Unusual Items
55,45637,84527,69617,84811,39214,041
Gain (Loss) on Sale of Investments
1,022807.241,0352,224592.1512.04
Gain (Loss) on Sale of Assets
-39.644.76-114.65-7.04-0.330.9
Asset Writedown
---2,241---
Pretax Income
56,43838,65726,37620,06611,98414,054
Income Tax Expense
14,5099,3856,4723,9652,6373,212
Earnings From Continuing Operations
41,92929,27219,90416,1019,34710,842
Minority Interest in Earnings
-2,109-1,494-299.18-557.26-216.6130.73
Net Income
39,82127,77819,60415,5449,13110,873
Net Income to Common
39,82127,77819,60415,5449,13110,873
Net Income Growth
99.98%41.69%26.12%70.24%-16.02%-
Shares Outstanding (Basic)
333334343434
Shares Outstanding (Diluted)
333334343434
Shares Change
-0.81%-2.28%-0.83%---
EPS (Basic)
1204.03839.66579.08455.33267.47318.50
EPS (Diluted)
1204.03839.66579.00455.00267.00318.50
EPS Growth
101.65%45.02%27.25%70.41%-16.17%-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
35,55328,78221,51031,798-10,07912,231
Free Cash Flow Per Share
1074.99870.02635.37931.49-295.24358.30
Dividend Per Share
250.000250.000200.000100.00075.00075.000
Dividend Growth
25.00%25.00%100.00%33.33%0%-
Gross Margin
26.33%25.26%25.52%31.26%30.18%30.95%
Operating Margin
10.12%9.43%8.43%12.47%10.38%12.96%
Profit Margin
7.58%5.82%5.10%9.40%5.87%8.40%
Free Cash Flow Margin
6.77%6.04%5.60%19.23%-6.48%9.45%
EBITDA
61,91253,31939,89624,32319,91819,580
EBITDA Margin
11.79%11.18%10.38%14.71%12.80%15.13%
D&A For EBITDA
8,7978,3297,5053,6923,7632,801
EBIT
53,11644,99032,39120,63116,15516,779
EBIT Margin
10.12%9.43%8.43%12.47%10.38%12.96%
Effective Tax Rate
25.71%24.28%24.54%19.76%22.00%22.86%
Advertising Expenses
-1,098873.74830.48690.36342.02